Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
8/1/2024 | Neutral | Northcoast | ||
7/31/2024 | Neutral → Outperform | Daiwa Securities | ||
7/29/2024 | Underperform → Peer Perform | Wolfe Research | ||
7/25/2024 | $100.00 → $70.00 | Buy → Hold | TD Cowen | |
7/25/2024 | $105.00 → $75.00 | Buy → Neutral | BofA Securities | |
7/25/2024 | $102.00 → $70.00 | Outperform → Neutral | Robert W. Baird | |
7/25/2024 | $105.00 → $72.00 | Overweight → Neutral | JP Morgan | |
7/25/2024 | $110.00 → $82.00 | Buy → Hold | Truist |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Citigroup analyst Paul Lejuez downgraded the rating for Lululemon Athletica Inc. (NASDAQ:LULU) from Buy to Neutral, while cutting the price target from $415 to $300. Lululemon shares settled at $272.06 on Wednesday. See how other analysts view this stock. See how other analysts view this stock. Argus Research analyst Kevin Heal downgraded Zions Bancorporation (NASDAQ:ZION) from Buy to Hold. Zions Bancorp shares closed at $50.98 on Wednesday. See how other analysts view this stock. B
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target from $85 to $70.
Oppenheimer analyst Suraj Kalia maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $100 to $90.
4 - TransDigm Group INC (0001260221) (Issuer)
4 - TransDigm Group INC (0001260221) (Issuer)
4 - Edwards Lifesciences Corp (0001099800) (Issuer)
Northcoast initiated coverage of Transdigm Group with a rating of Neutral
Daiwa Securities upgraded Edwards Lifesciences from Neutral to Outperform
Wolfe Research upgraded Edwards Lifesciences from Underperform to Peer Perform
CLEVELAND, Aug. 6, 2024 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the third quarter ended June 29, 2024. Third quarter highlights include: Net sales of $2,046 million, up 17% from $1,744 million in the prior year's quarter;Net income of $461 million, up 31% from the prior year's quarter;Earnings per share of $7.96, up 30% from the prior year's quarter;EBITDA As Defined of $1,091 million, up 19% from $915 million in the prior year's quarter;EBITDA
CONSOLIDATED HIGHLIGHTS Second Quarter 2024(1) Total revenue increased 4.6% to $2,900 million Property revenue increased 4.6% to $2,853 million Net income increased 96.8% to $908 million(2)(3) Adjusted EBITDA increased 8.1% to $1,890 million Net income attributable to AMT common stockholders increased 89.3% to $900 million(2)(3) AFFO attributable to AMT common stockholders increased 13.5% to $1,306 million American Tower Corporation (NYSE:AMT) today reported financial results for the quarter ended June 30, 2024. Steven Vondran, American Tower's Chief Executive Officer, stated, "The momentum from the start of the year extended into Q2, with core results highlighting
CLEVELAND, July 29, 2024 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG) today said it will report fiscal 2024 third quarter earnings before the market opens on Tuesday, August 6, 2024. A conference call will follow at 11:00 a.m., Eastern Time. To join the call telephonically, please register for the call here. Once registered, participants will receive the dial-in information and a unique pin to access the call. A live audio webcast of the call can also be accessed online at http://www.transdigm.com. The webcast will be archived on the website and available for replay
Waives Option to Classify Board Under Maryland Law Independence Realty Trust, Inc. (NYSE:IRT) ("IRT" or the "Company") today announced the appointment of Craig Macnab to its Board of Directors (the "Board"), effective February 29, 2024. Mr. Macnab brings over 20 years of experience to IRT's Board after serving in various executive and board roles in the REIT industry, including most recently as CEO of National Retail Properties, Inc. (NYSE:NNN) for 13 years. Mr. Macnab's appointment increases the size of IRT's Board to 10 members, including 8 independent directors. In connection with this announcement, the Company has entered into a cooperation agreement with Argosy-Lionbridge Management,
Charge Enterprises, Inc. (NASDAQ:CRGE) ("Charge" or the "Company"), announced today its Board of Directors has appointed Jacky Wu as an independent director, effective June 16, 2023. Mr. Wu's appointment expands the Board to ten members, six of whom are independent directors. Mr. Wu is currently the Executive Vice President and Chief Financial Officer of DigitalBridge Group, Inc., a global digital infrastructure investment firm (NYSE:DBRG). Prior to joining DigitalBridge, Mr. Wu was Executive Vice President and Chief Financial Officer of Driven Brands, Inc. (NASDAQ:DRVN), North America's largest automotive aftermarket platform. Prior to Driven Brands, Mr. Wu was Executive Vice President and
CLEVELAND, May 26, 2023 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG) ("the Company") announced today the upcoming retirement of Chief Operating Officer Jorge L. Valladares III, the appointment of Mr. Valladares to the Company's Board of Directors, the appointment of Mike Lisman and Joel Reiss as Co-Chief Operating Officers, and the appointment of Sarah Wynne as Chief Financial Officer. Retirement of Chief Operating Officer Jorge L. Valladares III Mr. Valladares will retire at the end of the TransDigm's 2023 fiscal year and has served as the Company's Chief Operatin
4 - AMERICAN TOWER CORP /MA/ (0001053507) (Issuer)
4 - Edwards Lifesciences Corp (0001099800) (Issuer)
4 - Edwards Lifesciences Corp (0001099800) (Issuer)
SC 13G/A - Edwards Lifesciences Corp (0001099800) (Subject)
SC 13G/A - AMERICAN TOWER CORP /MA/ (0001053507) (Subject)
SC 13G/A - TransDigm Group INC (0001260221) (Subject)
American Tower Corporation (NYSE:AMT) announced that its Board of Directors declared a quarterly cash distribution of $1.62 per share on shares of the Company's common stock. The distribution is payable on October 25, 2024 to the stockholders of record at the close of business on October 9, 2024. About American Tower American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of nearly 148,000 communications sites (excludes India assets sold) and a highly interconnected footprint of U.S. data center facilities. For more information about American Tower, please visit the "Investor Relatio
American Tower Corporation (NYSE:AMT) ("American Tower") today announced that it has closed the previously announced sale of 100% of the equity interests in its operations in India ("ATC India") to Data Infrastructure Trust ("DIT"), an Infrastructure Investment Trust sponsored by an affiliate of Brookfield Asset Management (NYSE:BAM, TSX:BAM) ("Brookfield"). Total cash proceeds to American Tower associated with the transaction represents approximately INR 210 billion, or $2.5 billion at today's exchange rates. Total cash proceeds include approximately $320 million associated with the monetization of optionally converted debentures issued by Vodafone Idea and payments on ATC India receivabl
Company announces $1 billion share repurchase Edwards Lifesciences (NYSE:EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE:BDX) for $4.2 billion in an all-cash transaction. The net proceeds from the sale will be used to fund strategic initiatives including the previously announced acquisitions and share repurchases. "Critical Care has made significant contributions to our company and has a long history of innovation. We are grateful to the team for their commitment to improving patient outcomes globally," said Bernard Zovighian, Edwards' CEO. "The sale of Critical Care reflects our sharpened focus as a structural heart
8-K - AMERICAN TOWER CORP /MA/ (0001053507) (Filer)
8-K - AMERICAN TOWER CORP /MA/ (0001053507) (Filer)
8-K - TransDigm Group INC (0001260221) (Filer)